Company CVAbout Gland Pharma Ltd 
Gland Pharma Ltd
Small Cap
Pharmaceuticals & Biotechnology
Gland Pharma Limited was incorporated as `Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, the name of the Company was changed to `Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 16.48 Cr
Number of Shares
16.48 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
07-Jun-2024
16.48
16.48
41200
1
Issued under ESOP Scheme
25-Mar-2024
16.47
16.47
2400
1
Issued under ESOP Scheme
14-Feb-2024
16.47
16.47
6200
1
Issued under ESOP Scheme
10-Oct-2023
16.47
16.47
1100
1
Issued under ESOP Scheme
29-Mar-2023
16.47
16.47
10600
1
Issued under ESOP Scheme
24-Nov-2022
16.47
16.47
1800
0
Issued under ESOP Scheme
24-Nov-2022
16.47
16.47
1800
1
Issued under ESOP Scheme
15-Sep-2022
16.47
16.47
32500
1
Issued under ESOP Scheme
15-Jun-2022
16.47
16.47
79400
1
Issued under ESOP Scheme
29-Apr-2022
16.46
16.46
273800
1
Issued under ESOP Scheme
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 26 Schemes (30.19%)
FIIs
Held by 206 FIIs (7.91%)
Promoter with highest holding
Fosun Pharma Industrial Pte. Ltd (51.83%)
Highest Public shareholder
Hdfc Mutual Fund - Hdfc Mid-cap Fund (6.34%)
Individual Investors Holdings
2.57%
Board of Directors
Management
Designation
Remuneration
Yiu Kwan Stanley Lau
Chairman & Independent Directo
57.4 lacs
SRINIVAS SADU
Managing Director & CEO
7.07 cr
QIYU CHEN
Non-Exec & Non-Independent Dir
0
UDO JAHANNES VETTER
Non-Exec & Non-Independent Dir
33.0 lacs
C S N Murthy
Independent Director
33.0 lacs
ESSAJI GOOLAM VAHANVATI
Independent Director
31.0 lacs
Naina Lal Kidwai
Independent Director
1.08 cr
Jia Ai (Allen) Zhang
Non-Exec & Non-Independent Dir
0
Yao Fang
Non-Exec & Non-Independent Dir
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
1,487 Cr
(Quarterly Results - Sep 2025)
Net Profit:
184 Cr
Pharmaceuticals & Biotechnology
INR 28,457 Cr (Small Cap)
36.00
34
1.04%
-0.25
8.27%
2.98
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
